25 September 2022 in Magnetic Resonance in Medicine
Purpose: This study aimed to develop a new 3D dual‐echo rosette k‐space trajectory, specifically designed for UTE MRI applications. The imaging of the ultra‐short transverse relaxation time (uT2) of brain was acquired to test the performance of the proposed UTE sequence.Theory and Methods: The rosette trajectory was developed based on rotations of a “petal‐like” pattern in the kx–ky plane, with oscillated extensions in the kz‐direction for 3D coverage. Five healthy volunteers underwent 10 dual‐echo 3D rosette UTE scans with various TEs. Dual‐exponential complex model fitting was performed on the magnitude data to separate uT2 signals, with the output of uT2 fraction, uT2 value, and long‐T2 value.Results: The 3D rosette dual‐echo UTE sequence showed better performance than a 3D radial UTE acquisition. More significant signal intensity decay in white matter than gray matter was observed along with the TEs. The white matter regions had higher uT2 fraction values than gray matter (10.9% ± 1.9% vs. 5.7% ± 2.4%). The uT2 value was approximately 0.10 ms in white matter .Conclusion: The higher uT2 fraction value in white matter compared to gray matter demonstrated the ability of the proposed sequence to capture rapidly decaying signals.
1 December 2020 in European Journal of Pharmaceutics and Biopharmaceutics
25 March 2024 in Magnetic Resonance in Medicine
22 July 2025 in Magnetic Resonance in Medicine
Purpose: This study aims (1) to implement a robust acquisition, fully automated reconstruction, and processing pipeline using a novel rosette k‐space pattern for UTE 31P 3D MRSI and (2) to evaluate the clinical applicability and reproducibility at different experimental setups.Methods: A multi‐center feasibility/reproducibility study was conducted for the novel UTE 31P 3D MRSI sequence with rosette petal trajectory (PETALUTE) at three institutions with different experimental setups (Siemens Prisma with volume head coil or surface coil, Siemens Biograph mMR with volume head coil). Five healthy subjects at each site were measured with an acquisition delay of 65 μs and a final resolution of 10 × 10 × 10 mm3 in 9 min. The measurement was repeated three times and averaged for the spectral analysis using the LCModel package. The potential for acceleration was assessed using compressed sensing on retrospectively undersampled data. Reproducibility at each site was evaluated using the inter‐subject coefficient of variance.Results: This novel acquisition and advanced processing techniques yielded high‐quality spectra and enabled the detection of the critical brain metabolites at three different sites with different hardware specifications. In vivo, feasibility with an acceleration factor of 4 in 6.75 min resulted in a mean Cramér‐Rao lower bounds below 20% for phosphocreatine (PCr), adenosine triphosphate (ATP), phosphomonoesters (PME), and a mean coefficient of variation for ATP/PCr below 20%.Conclusion: We demonstrated that UTE 31P 3D rosette MRSI acquisition, combined with compressed sensing and LCModel analysis, allows clinically feasible, robust, high‐resolution 31P MRSI to be acquired at clinical setups.
30 January 2024 in Magnetic Resonance in Medicine